Basal Cell Cancer Treatment. Therapeutic Experience With Vismodegib Therapy

Medical Council
doi 10.21518/2079-701x-2018-10-42-48
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Remedium, Ltd.

Related search

Granulation Tissue Masquerading as Basal Cell Carcinoma After Treatment With Vismodegib

JAAD Case Reports
Dermatology
2018English

035 Experiences With Smo Antagonist Vismodegib for the Treatment of Locally Advanced Basal Cell Carcinoma

Journal of Investigative Dermatology
BiochemistryDermatologyCell BiologyMolecular Biology
2017English

Vismodegib for Periocular and Orbital Basal Cell Carcinoma

JAMA Ophthalmology
Ophthalmology
2013English

New Developments in the Treatment of Basal Cell Carcinoma: Update on Current and Emerging Treatment Options With a Focus on Vismodegib

OncoTargets and Therapy
OncologyPharmacology
2018English

Vismodegib and Orbital Excision for Treating Locally Advanced Basal Cell Carcinoma

International Medical Case Reports Journal
Medicine
2018English

Lack of Response to Vismodegib in a Patient With Advanced Basal Cell Carcinoma: A Case Report

Journal of Clinical & Experimental Oncology
2017English

Photodynamic Therapy Combined With Cryotherapy for the Treatment of Nodular Basal Cell Carcinoma

Oncology Letters
Cancer ResearchOncology
2013English

Surgical Treatment of Periocular Basal Cell Carcinomas – 15 Years of Experience

Scripta Scientifica Medica
2014English

533 Pembrolizumab With or Without Vismodegib for Advanced Basal Cell Carcinoma: An Investigator-Initiated, Proof-Of-Concept Study

Journal of Investigative Dermatology
BiochemistryDermatologyCell BiologyMolecular Biology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy